Omnicell Inc. Stock
Omnicell Inc. Stock
Omnicell Inc. shows a slight decrease today, losing -€0.200 (-0.600%) compared to yesterday.
Omnicell Inc. is currently one of the favorites of our community with 11 Buy predictions and no Sell predictions.
As a result the target price of 37 € shows a slightly positive potential of 11.45% compared to the current price of 33.2 € for Omnicell Inc..
Pros and Cons of Omnicell Inc. in the next few years
Pros
?
G***** c******* t* c**********
?
C******** o* t** e**********
?
B****
Cons
?
M***** P*******
?
W********* I********* f** t** n*** y****
?
S********** s********
Tell us your opinion to access the 'Wisdom of the Crowds'
Performance of Omnicell Inc. vs. its peers
| Security | Change(%) | 1w | 1m | 1y | YTD | 3y | 5y |
|---|---|---|---|---|---|---|---|
| Omnicell Inc. | -0.600% | 10.596% | -21.596% | -10.695% | -13.918% | -33.200% | -67.885% |
| Healthequity Inc. | 0.790% | 6.504% | -7.092% | -36.408% | -16.026% | 6.504% | 0.000% |
| Bruker Corp. | 3.110% | 9.925% | -21.202% | -30.918% | -17.725% | - | - |
| Myriad Genetics | 1.100% | -4.813% | -27.935% | -73.824% | -32.830% | -79.446% | -84.966% |
Comments
Omnicell (NASDAQ:OMCL) was upgraded by analysts at Bank of America Corporation from a "neutral" rating to a "buy" rating. They now have a $70.00 price target on the stock.
Show more
Ratings data for OMCL provided by MarketBeat
Omnicell (NASDAQ:OMCL) had its "buy" rating reaffirmed by analysts at Benchmark Co..
Show more
Ratings data for OMCL provided by MarketBeat
Omnicell (NASDAQ:OMCL) had its "overweight" rating reaffirmed by analysts at Wells Fargo & Company.
Show more
Ratings data for OMCL provided by MarketBeat
News
Omnicell Executive Trims Holdings in $244,000 Sale as Stock Trades Near 2025 Highs
Corey J Manley, EVP & Chief Legal/Admin Officer at Omnicell (NASDAQ:OMCL), executed an open-market sale of 6,106 shares for $243,629.40 on Dec. 3, 2025, as reported in the SEC Form 4 filing.
Why Omnicell Stock Crushed the Market Today
Healthcare tech company Omnicell (NASDAQ: OMCL) was quite the picture of health on Thursday, at least as far as its equity was concerned. An encouraging quarterly earnings report sent its shares